Aardvark Therapeutics (AARD) Current Leases (2024 - 2026)
Aardvark Therapeutics (AARD) posted Current Leases of $336000.0 for Q1 2026, down 23.81% sequentially from $441000.0 in Q4 2025, and down 13.85% YoY from $390000.0 in Q1 2025.
Aardvark Therapeutics (AARD) Current Leases (2024 - 2026) Analysis & Trends
Aardvark Therapeutics has reported Current Leases for 3 years, with the latest figure at $336000.0 in Q1 2026.
- Quarterly Current Leases fell 13.85% year-over-year to $336000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $336000.0 (down 13.85% YoY) and the FY2025 annual result came in at $441000.0, up 30.47% from the prior year.
- Current Leases fell to $336000.0 in Q1 2026 per AARD's latest filing, from $441000.0 in the prior quarter.
- Over five years, Current Leases peaked at $441000.0 in Q4 2025 and troughed at $336000.0 in Q1 2026.
- A 3-year average of $391833.3 and a median of $403500.0 in 2025 frame the typical range for Current Leases.
- The sharpest annual moves came in 2025 and 2026: Current Leases surged 30.47% in 2025, then dropped 13.85% in 2026.
- Over 3 years, Current Leases stood at $338000.0 in 2024, then surged by 30.47% to $441000.0 in 2025, then dropped by 23.81% to $336000.0 in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $336000.0, $441000.0, and $429000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.14 Bn | 132.29 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 87.02 Bn | 79.03 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 65.30 Bn | 60.12 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.84 Bn | 55.70 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.15 Bn | 37.06 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.49 Bn | 28.18 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.78 Bn | 10.38 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.14 Bn | 26.31 Bn | - | - |
| 10 | Aardvark Therapeutics | 135.45 Mn | 61.53 Mn | - | 401,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 401,000.00 |
| Mar 31, 2026 | 336,000.00 |
| Dec 31, 2025 | 441,000.00 |
| Sep 30, 2025 | 429,000.00 |
| Jun 30, 2025 | 417,000.00 |
| Mar 31, 2025 | 390,000.00 |
| Dec 31, 2024 | 338,000.00 |